Results 101 to 110 of about 4,406,154 (211)

Tin(II) and Tin(IV) Complexes Incorporating the Oxygen Tripodal Ligands [(η⁵-C₅R₅)Co{P(OEt)₂O}₃]^-, (R = H, Me; Et = -C₂H₅) as Potent Inflammatory Mediator Inhibitors: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin. [PDF]

Molecules, 2023
Kalampalidis A, Damati A, Matthopoulos D, Tsoupras AB, Demopoulos CA, Schnakenburg G, Philippopoulos AI.   +6 more
europepmc   +1 more source

Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells

Drug Design, Development and Therapy, 2020
Fan Zhang,1 Lei Liu,2 Han Zhang,2 Zhe-Li Liu2 1Department of Ophthalmology, The Fourth Affiliated Hospital of China Medical University, Eye Hospital of China Medical University, Key Lens Research Laboratory of Liaoning Province, Shenyang, Liaoning ...
Zhang F, Liu L, Zhang H, Liu ZL
doaj  

Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer. [PDF]

Front Oncol, 2020
Souza JL, Martins-Cardoso K, Guimarães IS, de Melo AC, Lopes AH, Monteiro RQ, Almeida VH.   +6 more
europepmc   +1 more source

Atividade antiinflamatória e anti-nociceptiva de extratos e lignanas isolados de Phyllanthus amarus [PDF]

, 2006
Tese (doutorado) - Universidade Federal de Santa Catarina, Centro de Ciências Biológicas. Programa de Pós-Graduação em FarmacologiaO extrato hexânico (EH) obtido do Phyllanthus amarus reduziu a nocicepção em modelos experimentais de dor aguda e crônica ...
Kassuya, Candida Aparecida Leite
core  

QSAR study of platelet-activating factor (PAF) receptor binding antagonist

, 2013
The aim of this study was to find the structure activity relationship between the platelet-activating factor (PAF) receptor binding antagonist activity and the psychochemical properties of flavonoids 1-11 by using quantum chemical QSAR approach.
Abdullah, Nor Hayati, Ibrahim Ali , Noorbatcha, Ling, Sui Kiong   +2 more
core  

Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes

, 2002
It is known that myocardial ischaemia increases platelet aggregatory response to various agonists, ex vivo. We investigated the platelet aggregatory response to platelet activating factor (PAF), ex vivo, in patients with non-ST elevation acute coronary ...
Katsouras, C. S., Tselepis, A. D., Adamidis, K., Kolettis, T., Sideris, D. A., Tambaki, A. P., Goudevenos, J. A., Michalis, L. K.   +7 more
core  

Impact of targeting the platelet-activating factor and its receptor in cancer treatment

Military Medical Research
The lipid mediator platelet-activating factor (PAF) and its receptor (PAFR) signaling play critical roles in a wide range of physiological and pathophysiological conditions, including cancer growth and metastasis.
Kimya Qaderi, Arvin Shahmoradi, Anita Thyagarajan, Ravi P. Sahu   +3 more
doaj   +1 more source

Time Dependence of Whole Blood Aggregation in Response to Platelet Activating Factor (PAF)

, 1988
SummaryThe aggregation/adhesion response to platelet activating factor (PAF) was studied in diluted whole blood by impedance aggregometry. The extent of aggregation varied directly with the interval between blood sampling and aggregation measurement over
R Vandongen, J Strophair, R R Taylor, M Sturm, L J Beilin   +4 more
core   +1 more source

A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases?

, 1985
Platelets-isolated or in conjunction with leukocytes-interact with vessel walls in many experimental and human diseases. Several mediators are held responsible for platelet activation and interaction with leukocytes, among which PAF-acether (platelet ...
M Chignard, J Benveniste
core   +1 more source

Platelet Activating Factor(PAF) and Lyme Disease.

Nippon Saikingaku Zasshi, 1996
ISOGAI, Emiko, KIMURA, Koichi, ISOGAI, Hiroshi   +2 more
openaire   +3 more sources